Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds

A. R M Ruhul Amin, Phillip A. Karpowicz, Thomas E. Carey, Jack Arbiser, Rita Nahta, Zhuo G. Chen, Jin Tang Dong, Omer Kucuk, Gazala N. Khan, Gloria S. Huang, Shijun Mi, Ho Young Lee, Joerg Reichrath, Kanya Honoki, Alexandros G. Georgakilas, Amedeo Amedei, Amr Amin, Bill Helferich, Chandra S. Boosani, Maria Rosa CirioloSophie Chen, Sulma I. Mohammed, Asfar S. Azmi, W. Nicol Keith, Dipita Bhakta, Dorota Halicka, Elena Niccolai, Hiromasa Fujii, Katia Aquilano, S. Salman Ashraf, Somaira Nowsheen, Xujuan Yang, Alan Bilsland, Dong M. Shin

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to continue to proliferate, cancer cells must somehow uncouple themselves from the many signals that exist to slow down cell growth. Here, we define the anti-growth signaling process, and review several important pathways involved in growth signaling: p53, phosphatase and tensin homolog (PTEN), retinoblastoma protein (Rb), Hippo, growth differentiation factor 15 (GDF15), AT-rich interactive domain 1A (ARID1A), Notch, insulin-like growth factor (IGF), and Krüppel-like factor 5 (KLF5) pathways. Aberrations in these processes in cancer cells involve mutations and thus the suppression of genes that prevent growth, as well as mutation and activation of genes involved in driving cell growth. Using these pathways as examples, we prioritize molecular targets that might be leveraged to promote anti-growth signaling in cancer cells. Interestingly, naturally occurring phytochemicals found in human diets (either singly or as mixtures) may promote anti-growth signaling, and do so without the potentially adverse effects associated with synthetic chemicals. We review examples of naturally occurring phytochemicals that may be applied to prevent cancer by antagonizing growth signaling, and propose one phytochemical for each pathway. These are: epigallocatechin-3-gallate (EGCG) for the Rb pathway, luteolin for p53, curcumin for PTEN, porphyrins for Hippo, genistein for GDF15, resveratrol for ARID1A, withaferin A for Notch and diguelin for the IGF1-receptor pathway. The coordination of anti-growth signaling and natural compound studies will provide insight into the future application of these compounds in the clinical setting.

Original languageEnglish (US)
JournalSeminars in Cancer Biology
DOIs
StateAccepted/In press - 2015

Fingerprint

Carcinogenesis
Growth
Phytochemicals
Growth Differentiation Factor 15
Neoplasms
Phosphoric Monoester Hydrolases
Luteolin
Retinoblastoma Protein
Mutation
Curcumin
Genistein
Porphyrins
Somatomedins
Transcriptional Activation
Diet
Genes

Keywords

  • Anti-growth signaling
  • Cancer prevention
  • Hallmark of cancer
  • Reversible and irreversible evasion
  • Tumor suppressor

ASJC Scopus subject areas

  • Cancer Research

Cite this

Evasion of anti-growth signaling : A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. / Amin, A. R M Ruhul; Karpowicz, Phillip A.; Carey, Thomas E.; Arbiser, Jack; Nahta, Rita; Chen, Zhuo G.; Dong, Jin Tang; Kucuk, Omer; Khan, Gazala N.; Huang, Gloria S.; Mi, Shijun; Lee, Ho Young; Reichrath, Joerg; Honoki, Kanya; Georgakilas, Alexandros G.; Amedei, Amedeo; Amin, Amr; Helferich, Bill; Boosani, Chandra S.; Ciriolo, Maria Rosa; Chen, Sophie; Mohammed, Sulma I.; Azmi, Asfar S.; Keith, W. Nicol; Bhakta, Dipita; Halicka, Dorota; Niccolai, Elena; Fujii, Hiromasa; Aquilano, Katia; Ashraf, S. Salman; Nowsheen, Somaira; Yang, Xujuan; Bilsland, Alan; Shin, Dong M.

In: Seminars in Cancer Biology, 2015.

Research output: Contribution to journalArticle

Amin, ARMR, Karpowicz, PA, Carey, TE, Arbiser, J, Nahta, R, Chen, ZG, Dong, JT, Kucuk, O, Khan, GN, Huang, GS, Mi, S, Lee, HY, Reichrath, J, Honoki, K, Georgakilas, AG, Amedei, A, Amin, A, Helferich, B, Boosani, CS, Ciriolo, MR, Chen, S, Mohammed, SI, Azmi, AS, Keith, WN, Bhakta, D, Halicka, D, Niccolai, E, Fujii, H, Aquilano, K, Ashraf, SS, Nowsheen, S, Yang, X, Bilsland, A & Shin, DM 2015, 'Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds', Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2015.02.005
Amin, A. R M Ruhul ; Karpowicz, Phillip A. ; Carey, Thomas E. ; Arbiser, Jack ; Nahta, Rita ; Chen, Zhuo G. ; Dong, Jin Tang ; Kucuk, Omer ; Khan, Gazala N. ; Huang, Gloria S. ; Mi, Shijun ; Lee, Ho Young ; Reichrath, Joerg ; Honoki, Kanya ; Georgakilas, Alexandros G. ; Amedei, Amedeo ; Amin, Amr ; Helferich, Bill ; Boosani, Chandra S. ; Ciriolo, Maria Rosa ; Chen, Sophie ; Mohammed, Sulma I. ; Azmi, Asfar S. ; Keith, W. Nicol ; Bhakta, Dipita ; Halicka, Dorota ; Niccolai, Elena ; Fujii, Hiromasa ; Aquilano, Katia ; Ashraf, S. Salman ; Nowsheen, Somaira ; Yang, Xujuan ; Bilsland, Alan ; Shin, Dong M. / Evasion of anti-growth signaling : A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. In: Seminars in Cancer Biology. 2015.
@article{ab006cc2d8bb46ceb0ca28b1e426fe5a,
title = "Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds",
abstract = "The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to continue to proliferate, cancer cells must somehow uncouple themselves from the many signals that exist to slow down cell growth. Here, we define the anti-growth signaling process, and review several important pathways involved in growth signaling: p53, phosphatase and tensin homolog (PTEN), retinoblastoma protein (Rb), Hippo, growth differentiation factor 15 (GDF15), AT-rich interactive domain 1A (ARID1A), Notch, insulin-like growth factor (IGF), and Kr{\"u}ppel-like factor 5 (KLF5) pathways. Aberrations in these processes in cancer cells involve mutations and thus the suppression of genes that prevent growth, as well as mutation and activation of genes involved in driving cell growth. Using these pathways as examples, we prioritize molecular targets that might be leveraged to promote anti-growth signaling in cancer cells. Interestingly, naturally occurring phytochemicals found in human diets (either singly or as mixtures) may promote anti-growth signaling, and do so without the potentially adverse effects associated with synthetic chemicals. We review examples of naturally occurring phytochemicals that may be applied to prevent cancer by antagonizing growth signaling, and propose one phytochemical for each pathway. These are: epigallocatechin-3-gallate (EGCG) for the Rb pathway, luteolin for p53, curcumin for PTEN, porphyrins for Hippo, genistein for GDF15, resveratrol for ARID1A, withaferin A for Notch and diguelin for the IGF1-receptor pathway. The coordination of anti-growth signaling and natural compound studies will provide insight into the future application of these compounds in the clinical setting.",
keywords = "Anti-growth signaling, Cancer prevention, Hallmark of cancer, Reversible and irreversible evasion, Tumor suppressor",
author = "Amin, {A. R M Ruhul} and Karpowicz, {Phillip A.} and Carey, {Thomas E.} and Jack Arbiser and Rita Nahta and Chen, {Zhuo G.} and Dong, {Jin Tang} and Omer Kucuk and Khan, {Gazala N.} and Huang, {Gloria S.} and Shijun Mi and Lee, {Ho Young} and Joerg Reichrath and Kanya Honoki and Georgakilas, {Alexandros G.} and Amedeo Amedei and Amr Amin and Bill Helferich and Boosani, {Chandra S.} and Ciriolo, {Maria Rosa} and Sophie Chen and Mohammed, {Sulma I.} and Azmi, {Asfar S.} and Keith, {W. Nicol} and Dipita Bhakta and Dorota Halicka and Elena Niccolai and Hiromasa Fujii and Katia Aquilano and Ashraf, {S. Salman} and Somaira Nowsheen and Xujuan Yang and Alan Bilsland and Shin, {Dong M.}",
year = "2015",
doi = "10.1016/j.semcancer.2015.02.005",
language = "English (US)",
journal = "Seminars in Cancer Biology",
issn = "1044-579X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Evasion of anti-growth signaling

T2 - A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds

AU - Amin, A. R M Ruhul

AU - Karpowicz, Phillip A.

AU - Carey, Thomas E.

AU - Arbiser, Jack

AU - Nahta, Rita

AU - Chen, Zhuo G.

AU - Dong, Jin Tang

AU - Kucuk, Omer

AU - Khan, Gazala N.

AU - Huang, Gloria S.

AU - Mi, Shijun

AU - Lee, Ho Young

AU - Reichrath, Joerg

AU - Honoki, Kanya

AU - Georgakilas, Alexandros G.

AU - Amedei, Amedeo

AU - Amin, Amr

AU - Helferich, Bill

AU - Boosani, Chandra S.

AU - Ciriolo, Maria Rosa

AU - Chen, Sophie

AU - Mohammed, Sulma I.

AU - Azmi, Asfar S.

AU - Keith, W. Nicol

AU - Bhakta, Dipita

AU - Halicka, Dorota

AU - Niccolai, Elena

AU - Fujii, Hiromasa

AU - Aquilano, Katia

AU - Ashraf, S. Salman

AU - Nowsheen, Somaira

AU - Yang, Xujuan

AU - Bilsland, Alan

AU - Shin, Dong M.

PY - 2015

Y1 - 2015

N2 - The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to continue to proliferate, cancer cells must somehow uncouple themselves from the many signals that exist to slow down cell growth. Here, we define the anti-growth signaling process, and review several important pathways involved in growth signaling: p53, phosphatase and tensin homolog (PTEN), retinoblastoma protein (Rb), Hippo, growth differentiation factor 15 (GDF15), AT-rich interactive domain 1A (ARID1A), Notch, insulin-like growth factor (IGF), and Krüppel-like factor 5 (KLF5) pathways. Aberrations in these processes in cancer cells involve mutations and thus the suppression of genes that prevent growth, as well as mutation and activation of genes involved in driving cell growth. Using these pathways as examples, we prioritize molecular targets that might be leveraged to promote anti-growth signaling in cancer cells. Interestingly, naturally occurring phytochemicals found in human diets (either singly or as mixtures) may promote anti-growth signaling, and do so without the potentially adverse effects associated with synthetic chemicals. We review examples of naturally occurring phytochemicals that may be applied to prevent cancer by antagonizing growth signaling, and propose one phytochemical for each pathway. These are: epigallocatechin-3-gallate (EGCG) for the Rb pathway, luteolin for p53, curcumin for PTEN, porphyrins for Hippo, genistein for GDF15, resveratrol for ARID1A, withaferin A for Notch and diguelin for the IGF1-receptor pathway. The coordination of anti-growth signaling and natural compound studies will provide insight into the future application of these compounds in the clinical setting.

AB - The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to continue to proliferate, cancer cells must somehow uncouple themselves from the many signals that exist to slow down cell growth. Here, we define the anti-growth signaling process, and review several important pathways involved in growth signaling: p53, phosphatase and tensin homolog (PTEN), retinoblastoma protein (Rb), Hippo, growth differentiation factor 15 (GDF15), AT-rich interactive domain 1A (ARID1A), Notch, insulin-like growth factor (IGF), and Krüppel-like factor 5 (KLF5) pathways. Aberrations in these processes in cancer cells involve mutations and thus the suppression of genes that prevent growth, as well as mutation and activation of genes involved in driving cell growth. Using these pathways as examples, we prioritize molecular targets that might be leveraged to promote anti-growth signaling in cancer cells. Interestingly, naturally occurring phytochemicals found in human diets (either singly or as mixtures) may promote anti-growth signaling, and do so without the potentially adverse effects associated with synthetic chemicals. We review examples of naturally occurring phytochemicals that may be applied to prevent cancer by antagonizing growth signaling, and propose one phytochemical for each pathway. These are: epigallocatechin-3-gallate (EGCG) for the Rb pathway, luteolin for p53, curcumin for PTEN, porphyrins for Hippo, genistein for GDF15, resveratrol for ARID1A, withaferin A for Notch and diguelin for the IGF1-receptor pathway. The coordination of anti-growth signaling and natural compound studies will provide insight into the future application of these compounds in the clinical setting.

KW - Anti-growth signaling

KW - Cancer prevention

KW - Hallmark of cancer

KW - Reversible and irreversible evasion

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=84926444126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926444126&partnerID=8YFLogxK

U2 - 10.1016/j.semcancer.2015.02.005

DO - 10.1016/j.semcancer.2015.02.005

M3 - Article

C2 - 25749195

AN - SCOPUS:84926444126

JO - Seminars in Cancer Biology

JF - Seminars in Cancer Biology

SN - 1044-579X

ER -